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ABSTRACT
Inhibitors which inhibit the angiotensin I-converting enzyme(ACE) were prepared from tryp-
sin digests of croaker extracts. The inhibitory activity of ACE detected in the trypsin degests of
croaker extracts was fractionated into two major phosphopeptides fractions of P-I and P-2 by gel fil-
tration chromatography on sephadex G-50.
The inhibition of ACE of the two kinds of phosphopeptides fractions of P-I and P-2 was inves-
tigated in vitro.
The ICso values of p-l and p-2 of phosphopeptides for ACE were 0.18 and lO.2mg protein/me,
respectively.
In addition, the ACE inhibitor of P-1 and P-2 were further purified by ultrafiltration and by
sephadex G-I 5 and G-25 chromatography. ACE inhibitory activity was fractionated into three ma-
jor phosphopeptides fractions of P-I-I, P-I-2 and P-l-3 from the trypsin digests of the P-1,
and into three major fractions of P-2-1, P-2-2 and P-2-3 from the trypsin digests of the P-2 by gel fil-
tration rechromatography on sephadex G-15 and G-25, respectively.
The inhibition of ACE of the six kinds of phosphopeptides fractions (P-1-1, P-1-2, P-I-
3, P-2-1, P-2-2 and P-2-3) was analyzed in vitro.
The IC50 values of P-I-1, P-I-2, P-I-3, P-2-1, P-2-2 and P-2-3 of phosphopep-
tides for ACE were 1.12, 1.84, 0.15, 0.70, 4.80 and 1.98mg protein/me, respectively.
The P-I-3 fraction had most inhibition activity and showed 0.15 mg protein/me inhibition
against ACE at lCoo value.
The amino acid compositions of the phosphopeptides fractions (P-1-1, P-I-2, P-1-3, P-
2-1, P-2-2 and P-2-3) were characterized by relatively high percentage for Glu, Asp, Gly, Ala,
Val, Leu, Tyr, Lys and Arg.
INTRODUCTION
Our interest has been focused on the preparation and isolation of phosphopeptides from natural
resources that are involved in blood pressure regulation.
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Many investigators have tried to prepare and isolate the ACE inhibitory peptides (1 ~ !OJ.
To date, there is still no report on the ACE inhibitory activity of phosphoproteins and phos-
phopeptides in nature.
In previous paperOl-161, auther et. al. have reported that the inhibitory activity of ACE detected
from digests by proteolytic enzymes such as pepsin, trypsin and chymotrypsin of oyster extracts was
fractionated into two major fractions of high molecular weight and low molecular weight by gel fil-
tration chromatography on Sephadex 0-50, 0-25 and 0-15.
In this investigation, the ACE inhibitors was detected two major phosphopeptides of P-l and P-
2 in the trypsin digests of guchi extracts by Sephadex 0-50 column chromatography. The P-l and P
-2 had high inhibitory activity against ACE at ICso value.
Therefore, P-l and P-2 of ACE inhibitors were further purified by ultrafiltration and by
Sephadex 0-25 and 0-15 chromatography.
MATERIALS AND METHODS
Materials:
Sephadex 0-15 was a product of Pharmacia. Proteolytic enzymes (trypsin) were obtained from
Boehringer Co. ACE from rabbit lung acetone powder was obtained from Sigma Chemical Co. (U.S.
A.) .
Hippuryl-L-histidyl-leucine (HHL) as a substrate was obtained from the Peptide Institute
(Osaka, Japan) .
All other reagents were obtained from Nacalai Tesque (Kyoto, Japan).
Assay of ACE inhibitory activity :
The activity of ACE inhibition was assayed by the method of Yamamoto et. al. (J7).
For each assay, 100,u 1 of ACE inhibitor and 50,u 1 of Hip -His -Leu (2.5 mM in a borate buffer
containing 200 mM NaCl at pH 8.3) were incubated with 100,ul of 2.5mu/me of ACE at 37°Cfor
30 min. The reaction was stopped by adding 250,u 1 of IN HC1, and 1.5me of ethyl acetate was then
added to the mixture, and the mixture was shaked for 30 sec. The mixture was centrifuged at 2500
rpm for lOmin., and 1.25me from the supernatant was transfered to test tube, and then heated at 120°C
for 45min., 0.5me of 1 M NaCl was then added to the dried material, and the solution was shaked for
30 sec., and the absorbance of the yielded hippuric acid at 228 nm was measured with a Hitachi 101
spectrophotometer.
The ACE inhibitor concentration required to inhibit 50 % of the ACE activity is defineed as the
ICso value.
Fractionation of inhibitor from croaker extracts by column chromatography:
After the precipitate of croaker extracts had been removed by centrifugation at 3000 rpm for 25
min., the supernatant was then applied to a 2.5x 40cm column of sephadex 0-50.
The column was eluted with 500me of distillated water. The eluate was collected in lOme frac-
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tions, while monitoring the absorbance at 280nm for phosphopeptides and at 820nm for total phos-
phorus. The peaks were denoted as P-I and P-2. The each peak was collected, and determined the
amino acid and ACE inhibitory activity.
Isolation and purification of ACE inhibitors from trypsin digests of croaker extracts :
The freeze-dried powder about 450mg of P-I and P-2 obtained by Sephadex G-50 chromatogra-
phy were dissolved in lO~ of 0.0 I M Tris-HCI buffer(pH 8.0), and then lOmg of trypsin was added
to the mixture, and the mixture incubated at 37°C for 24 hrs. After reaction, the incubation mixture
was then heated for 15min. in a boiling-water bath.
After the precipitate had been removed by centrifugation at 14000 rpm for l5min., the superna-
tant was then ultrafiltrated with membrane filter(MW Cutoff 2000; Amicon).
The filtrate was then applied to a 2.5 x 40cm column of Sephadex G-25 and G-15(prewashed
with water). The column was eluted with 250~ of distillated water.
The eluate was collected in 5~ fractions, while monitoring the absorbance at 280nm for phos-
phopeptides and at 820nm for total phosphorus. Each fraction was collected, and determined the
amino acid and ACE inhibitory activity.
Quantitative analysis :
Total phosphorus was estimated by the method of Chen et. al'lRi. Amino acid analyses were
carried out with a lTC-200A amino acid analyzer. The sample for amino acid analyses was hydro-
lyzated in 6 N HCI at llOoC for 24hrs. The nitrogen and protein were analyzed in the usual way (%
protein=%Nx 6.25).
RESULTS AND DISCUSSION
Fig 1 showed the Sephadex G-50 column chromatogram of the tryptic hydrolyzates of croker.
The experimental details are described in the text.
The entire effluent was collected in tubes on a fraction collector for quantitative analysis of the
total phosphorus and for qualitative analysis of the phosphopeptides at 280nm. Phosphorus-
containing two peaks and two peaks of peptides at 280nm were eluted from the column in the case of
tryptic hydrolyzates. The first peak and second peak designated as P-I and P-2, respectively.
The maximum total-phosphorus content was observed in fraction No.7 in the case of P-l, and
in fraction No.22 in the case of P-2 as shown in the Fig.l.
In addition, the maximum absorption at 280nm was observed in fraction No.7 in the case of P-l,
and in fraction No.20 in the case of P-2. Fraction No.3 ~ lOaf the P-l and fraction No.ll ~ 26 of
the P-2 were pooled, and analysed for ACE inhibitory activity and amino acids.
The inhibition of ACE of the P-I and P-2 was investigated in vitro. It has been demonstrated
that P-l and P-2 had high inhibitory activity and showed 0.18 and 1O.24mg protein/~ inhibition
against ACE at ICo value.
Therefore, the P-l and P-2 of ACE inhibitors were further purified by ultrafiltration and
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Fig. 1. Chromatographic Profile of Phospho-
peptides Eluted by Sephadex 0-50 Col-
umn Chromatography from the Enzy-
matic Hydrolyzates of Extracts of Croaker,
Argyrosomus argentatus.
The experimental details are described
in the text.
+-+ indicate total-phosphorus and .-
• indicate phosphopeptides at 280nm
in the collected fractions. P-I and P-2
represent combined fractions 3 ~ 10 and
fractions I I ~ 26, respectively.
Fig. 2. Chromatographic Profile of Phospho-
peptides by Rechromatography on Sephadex
0- 15 Column of Trypsin digests of Ac-
tive Fraction (P-I) Obtained by
Sephadex 0-50 Chromatography.
The experimental details are described
in the text.
+-+ indicate total-phosphorus and.
-. indicate phosphopeptides at 280nm
in the collected fractions. P-I-I, P-I-2
and P-I-3 represent combined fractions
No. 12~ 19, fractions No.22~ 31 and
fractions 37~45, respectively.
Sephadex 0-15 and 0-25 chromatography.
Fig.2 shows the chromatographic profile of phosphopeptides by rechromatography on
Sephadex 0-15 column of trypsin digest of most active fraction(P-l) obtained from Sephadex 0-50
chromatography.
The experimental details are described in the text. The entire effluent was collected in tubes on
a fraction collector for quantitative analysis of the total-phosphorus and for qualitative analysis of
the phosphopeptides at 280nm.
Phosphorus-containing three peaks and three peaks of peptides at 280nm were eluted from the
column in the case of tryptic hydrolyzates of P-l. The first peak, second peak and third peak desig-
nated as P-l-l, P-1-2 and P-1-3, respectively.
The maximum total-phosphorus content was observed in fraction No.15 in the case of P-l-l,
and in fraction No.26 in the case of P-1-2, and in fraction NoAO in the case of P-1-3 as shown in the
Fig 2.
In addition, the maximum absorption at 280nm was observed in fraction No.16 in the case of P-
I-I in fraction No.27 in the case of P-I-2 and in fraction NoA! in the case of P-I-3. Fraction No.12
~19 of the P-l-l, fraction No.22~3l of the P-I-2 and fraction No.37~45 of the P-I-3 were
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pooled, and analysed for amino acids and ACE inhibitory activity.
Fig.3 show the chromatographic profile of phosphopeptides by rechromatography on Sephadex
G-15 column of trypsin digest of active fraction (P-2) obtained from Sephadex G-50 chromatogra-
phy. The experimental details are described in the text.
The entire effluent was collected in tubes on a fraction collector for quantitative analysis of the
total-phosphorus and for qualitative analysis of the phosphopeptides at 280nm.
Tablel. Phosphorus Contents of the P- 1 -1, P- 1 -
2, P-I-3, P-2-1, P-2-2 and P-2-3 Frac-
tionated by Rechromatography on Sephadex G-15 and
G-25 Columu of Trypsin Digests of P- 1 and P- 2
obtained by Sephadex G-50 Chromatography of Ex-
tracts of Croaker, Argyosomus Argentatus.
P-2.
The phosphorus-containing three peaks and
three peaks of peptides at 280nm were eluted from
the column in the case of tryptic hydrolyzates of
Fig. 3. Chromatographic Profile of Phospho-
peptides by Rechromatography on
Sephadex G-25 Column of Trypsin di-
gests of Active Fraction (P-2) Obtained
by Sephadex G-50 Chromatography.
The experimental details are described
in the text.
The first peak, second peak and third peak +-+ indicate total - phosphorus and
.-. indicate phosphopeptides at 280
designated as P-2-1, P-2-2 and P-2-3, respectively. nm in the collected fractions. P-2-I, P-2
The maximum total-phosphorus content was -2 and P-2-3 represent combined frac-
tions No.13 ~ 19, fractions No.20 ~ 32
observed in fraction No.16 in the case of P-2-1, and fractions 33 ~ 43.respectively.
and in fraction No.30 in the case of P-2-2 and in fraction No.36 in the case of P-2-3 as shown in the
Fig.3.
In addition, the maximum absorption at 280nm was observed in fraction No.16 in the case of P-
2-1, and in fraction No.30 in the case of P-2-2 and in fraction No.38 in the case of P-2-3. Fraction
No.13~19 of the P-2-1, fraction No.20~32 of the P-2-2 and fraction No.33~43 of the P-2-3 were
pooled, and analyzed for amino acids and ACE inhibitory activity.
In Table 1 is reported the phosphorus contents of the P-l, P-2, P-l-l, P-I-2, P-I-3, P-2-1, P-2-2,
P-2-3 eluted by chromatography on Sephadex G-50, G-25 and G-15 column from croaker extracts.
The total-phosphorus content in the P-l, P-2, P-l-1, P-1-2, P-2-1, P-2-2 and P-2-3 fractions
were 37.6,839.9,141.6,150.9,99.0,46.7,201.1 and 55.2 p.g per rr~ of the fraction, respectively.
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Table2. Amino Acid Composition of Phosphopeptides in the P-I, P-2,
P-I-I, P-I-2, P-I-3, P-2-1, P-2-2 and P-2-3 Fractionated by Re-
chromatography on Sephadex G-15 and G-25 Column of Tryp-
sin Digests of the P-I and P-2 Obtained by Sephadex G-50
Chromatography.
(flg/mg . N)
Amino p- 1- 1 p- 1 - 2 p- 1- 3 p- 2 - 1 p- 2 - 2 p- 2 - 3
Acid
Asp 13. 71 20.14 5.88 53.11 1. 76 2.28
Thr 6.49 8.05 3.35 10.11 0.68 1. 09
Ser 11.39 14.57 12.65 14.51 0.80 1. 28
Glu 11.13 16.33 7.35 34.04 3.22 2.42
Gly 10.05 20.81 8.90 51.18 8.80 25. 75
Ala 7.43 13.95 2.94 15.89 2.59 7.01
Cys 0.00 0.00 0.00 1. 20 0.00 0.30
Val 6.69 21. 24 6. 78 6.84 1.34 1. 96
Met 0.00 1. 05 0.00 0.20 0.44 5.14
lIeu 6.02 12.43 8.16 3.53 O. 74 1.46
Leu 11. 76 12.90 3.51 6. 78 1. 31 4.54
Tyr 15.09 23.43 29.63 13.80 0.44 4.25
Phe 0.00 7.62 0.00 6.11 0.52 14.39
His 9.01 25.19 15.51 6.93 0.26 4.24
Lys 4. 77 46.19 2. 78 11.42 1. 61 0.56
Arg 2.45 4.48 2.04 7.40 0.86 0.95
Pro 7.53 22.00 2.20 31. 62 4.48 10.35
Total 123.52 270.38 111. 68 274.67 29.85 87.97
Table 2 summarises the amino acid composition of the P-I, P-2, P-I-l, P-I-2, P-I-3, P-2-1, P-2
-2 and P-2-3 fractions. Of note in P-l, P-2, P-l-l, P-1-2, P-I-3, P-2-1, P-2-2 and P-2-3 is the very
high acidic amino acids(Asp and Glu), Gly, Ala, Val, Leu, Tyr, Phe, Lys and Arg content.
Cheung et. al (19). and Matsui et.al (4) • have reported that it was essential for strong and com-
petitive ACE inhibition that a peptide had aromatic amino acid residues at the C-terminal (i.e., Try.
Tyr. Pro.), and hydrophobic or basic ones at the N-terminal.
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Table 3. Angiotensin-l Converting Enzyme Inhibitory Activity of the P-I, P-
2, P-I-I, P-I-2, P-I-3, P-2-1, P-2-2, and P-2-3 of Phosphopeptides
obtained by Rechromatography on Sephadex G-15 and G-25 Column
of tryptic Hydrolyzates of P-I and P-2 obtained by Sephadex G-50
Column Chromatography.
Fraction Protein (rug / me ) IC·,() (mg protein/me)
P- 1 0.150 0.179
P- 2 17.938 10.240
P- 1 - 1 0.372 1.116
P- 1 - 2 0.262 1.840
P- 1 - 3 0.153 0.152
P- 2 - 1 0.563 O. 700
P- 2 - 2 9.988 4.802
P- 2 - 3 2.125 1.980
Table 3 shows angiotensin converting enzyme inhibitory activity of the P-l, P-2, P-I-I, P-I-2,
P-I-3, P-2-l, P-2-2 and P-2-3 phosphopeptides eluted by Sephadex G-50, G-25 and G-15 column
chromatography.
The ICoo values for P-l, P-2, P-l-l, P-1-2, P-1-3, P-2-1, P-2-2 and P-2-3 were 0.18, 10.24, 1.12,
1.84, 0.15, 0.70, 4.80 and 1.98 mg protein/me, respectively.
The P-1-3 fraction had most inhibition activity and showed 0.15 mg protein/me inhibition
against ACE at ICoo value, and the lCoo value in the P-1-3 fraction was 1.2,67,7,12,4.6,31 and 13
times higher than those in the P-l, P-2, P-l-l, P-I-2, P-2-1, P-2-2 and P-2-3 fractions, respectively.
These results suggest that the phosphopeptide fractions are a mixture of several phosphopep-
tides.
In addition, the results above, it has been demonstrated that the isolated peptide inhibitors oc-
curs as the phosphate-containing phosphopeptides, but more experiments will be needed to prove
the ACE inhibition of the phosphopeptides isolated from Croaker, argyrosomus argentatus.
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